Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00619_DB00864_nanopub.RANxRHCk0YZZvtkTlmwDmeXdUWzw_8LJ5pxTgi3pesbyY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00619_DB00864 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00619_DB00864 label "DDI between Imatinib and Tacrolimus - The strong CYP3A4 inhibitor, Imatinib, may decrease the metabolism and clearance of Tacrolimus, a CYP3A4 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Tacrolimus if Imatinib is initiated, discontinued or dose changed. [drugbank_resource:DB00619_DB00864]" assertion.
- drugbank_resource:DB00619_DB00864 identifier "drugbank_resource:DB00619_DB00864" assertion.
- drugbank_resource:DB00619_DB00864 title "DDI between Imatinib and Tacrolimus - The strong CYP3A4 inhibitor, Imatinib, may decrease the metabolism and clearance of Tacrolimus, a CYP3A4 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Tacrolimus if Imatinib is initiated, discontinued or dose changed." assertion.
- drugbank:DB00864 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00619_DB00864 assertion.
- drugbank:DB00619 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00619_DB00864 assertion.